Skip to search formSkip to main contentSkip to account menu

NSC-104800

Known as: NSC 104800, NSC104800 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Mitolactol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1982
1982
Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man--II. pharmacokinetics of DBD.
1981
1981
The effect of dibromo-dulcitol and dianhydro-dulcitol (galactitol) on RNA synthesis in ascites tumor cells.
The mechanism of action on RNA synthesis of anticancer dibromo-dulcitol (DBD, NSC-104800) and dianhydro-dulcitol (DAD, or… 
1979
1979
Metabolism and pharmacokinetics of dibromodulcitol (DBD, NSC-104800) in man. I. Metabolites of DBD.
1972
1972
Effects of combination therapy with bleomycin (NSC-125066) and dibromodulcitol (NSC-104800) on squamous cell carcinoma in man.
1971
1971
Phase I study of dibromodulcitol (NSC-104800).
1971
1971
Clinical experiences with dibromodulcitol (NSC-104800) in solid tumors.
1971
1971
Phase II study of dibromodulcitol (NSC-104800).
1971
1971
Initial clinical trial of dibromodulcitol (NSC-104800) in patients with advanced cancer.
1971
1971
Initial clinical trial of dibromodulcitol (NSC-104800) in patients with advanced cancer.
1969
1969
Clinical and pharmacologic experience with dibromodulcitol (NSC-104800). A new antitumor agent.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)